Answers are grounded in this paper and cite their sources.
Meta-analysis compares nephro-urological outcomes in fetuses with lower urinary tract obstruction, revealing technical challenges and similar results.
Purpose: To compare obstetrical, survival, and nephro-urological outcomes of fetuses diagnosed with lower urinary tract obstruction (LUTO) undergoing antenatal procedures by vesicoamniotic shunting (VAS) or fetal cystoscopy (FC). Methods: This study was a literature search using MEDLINE, Scopus, Embase, and Cochrane reference lists. All studies reporting VAS and FC's effectiveness, complications, and technical issues in the prenatal treatment of LUTO were selected for a single-proportion meta-analysis. Two reviewers independently selected studies, extracted data, and assessed quality. We computed and declared effect sizes for estimating a single proportion using the Freeman-Turkey transformed proportion. Results: out of a total of 467 citations identified, 49 studies were included for a detailed evaluation of VAS and FC perinatal outcomes. Overall, VAS and FC were burdened by a similar incidence of intrauterine fetal demise [VAS: 0.51 (0.42-0.61) versus FC: 0.47 (0.28-0.67); p=0.73], postnatal death [VAS: 0.87 (0.75-0.99) versus FC: 0.86 (0.62-1.09); p-value: 0.87], and postnatal renal impairment [VAS: 1.22 (1.06-1.39) versus FC: 0.96 (0.67-1.25); p-value: 0.12]. Likewise, the two procedures were complicated by a similar rate of chorioamnionitis [VAS: 0.38 (0.28-0.47) versus FC: 0.39 (0.12-0.66); p-value: 0.92], premature rupture of membranes/preterm premature rupture of membranes (PROM/PPROM) [VAS: 0.77 (0.60-0.94) versus FC: 0.84 (0.60-1.07); p-value: 0.65], premature birth [VAS: 1.83 (1.55-2.10) versus FC: 1.56 (0.92-2.21): p-value: 0.46], and fetal abdominal wall/intestinal problems [VAS: 0.43 (0.29-0.57) versus FC: 0.50 (0.19-0.81); p-value: 0.69]. Termination of pregnancy (TOP) was chosen significantly more often after FC than VAS [VAS: 0.65 (0.53-0.77) versus FC: 1.18 (1.03-1.33); p-value: < 0.001]. Conclusion: Our meta-analysis yields similar results in terms of obstetric, survival, and nephro-urological outcomes between VAS and FC. The higher incidence of TOP in FC over the VAS group may be associated with the fact that FC is also considered a diagnostic tool and can guide for TOP for those with more complex diseases.
No takes yet. Share an insight, caveat, or question.
Paraboschi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: